Yeda Research And Development Co., Ltd. opposition analysis

COMPANY ANALYSIS

Latest patents of Yeda Research And Development Co., Ltd. opposed by its competitors

Patent:
Grant Date:
Jul 27, 2022
Title:
Redirected, Genetically-Engineered T Regulatory Cells And Their Use In Suppression Of Autoimmune And Inflammatory Disease
Oppositions:
1
Patent:
Grant Date:
Jul 11, 2018
Title:
Dosing Regimen For Multiple Sclerosis
Oppositions:
5

Competitors of Yeda Research And Development Co., Ltd.

ALVOGEN IPCO S.A.R.L.

GENERICS [UK] LIMITED (TRADING AS MYLAN)

G. L. PHARMA GMBH

Want to track Yeda Research And Development Co., Ltd.?

Feel free to send us a message here and we will get back to you